J. Morris
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Gastric Cancer Management and Outcomes, Hepatocellular Carcinoma Treatment and Prognosis, Esophageal Cancer Research and Treatment, Lymphoma Diagnosis and Treatment, Liver Disease Diagnosis and Treatment
Most-Cited Works
- → Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy.(1987)219 cited
- → Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma(2015)106 cited
- → Preoperative induction of CPT‐11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction(2004)68 cited
- → Clinical and prognostic significance of circulating levels of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma(2018)19 cited
- → A Phase II study of sorafenib and yttrium-90 glass microspheres for advanced hepatocellular carcinoma, BCLC stage C(2017)2 cited
- → Association between the job types and the risk of hepatocellular carcinoma in the United States(2016)2 cited
- → Size and number of examined lymph nodes impacts outcome in patients with stage II colorectal cancer(2004)2 cited
- → Celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, ameliorated capecitabine (X) hand & foot syndrome (HFS) & enhanced survival in metastatic colorectal cancer (MCRC)(2004)1 cited
- → The number of abnormalities on pre-treatment PET scan predicts for overall survival of patient with localized esophageal and GE junction carcinoma (E/GEJC)(2004)
- → Access to Mammography in the South: a Spatial Perspective(2012)